DR. IVOR JOHN PERCENT M.D. NPI 1619053998

NPI Details

DR. Ivor John Percent, M.D. is a medical oncology internal medicine in Port Charlotte, FL with 24 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Ivor John Percent, M.D. NPI is 1619053998. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE IN NEW ORLEANS
Graduation Year:2002

The provider's business location address is:

22395 EDGEWATER DR
PORT CHARLOTTE, FL
ZIP 33980-012
Phone: (941) 766-7222
Fax: (941) 766-0970

The NPI 1619053998 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg (HCPCS:J1569)
• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg (HCPCS:Q5118)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, mepolizumab, 1 mg (HCPCS:J2182)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Ferritin (blood protein) level (HCPCS:82728)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Iron level (HCPCS:83540)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, iron dextran, 50 mg (HCPCS:J1750)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Folic acid level, serum (HCPCS:82746)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Iron binding capacity (HCPCS:83550)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Protein measurement, serum (HCPCS:84165)
• Red blood count, manual test (HCPCS:85044)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Red blood count, automated test (HCPCS:85045)
• Injection of drug or substance into vein (HCPCS:96374)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Magnesium level (HCPCS:83735)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Automated urinalysis test (HCPCS:81003)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, furosemide, up to 20 mg (HCPCS:J1940)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Blood test, clotting time (HCPCS:85610)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Drawing of blood for a medical problem (HCPCS:99195)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Red blood count automated, with additional calculations (HCPCS:85046)
• Urinalysis, manual test (HCPCS:81002)
• Erythropoietin (protein) level (HCPCS:82668)
• Phosphate level (HCPCS:84100)
• Uric acid level, blood (HCPCS:84550)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Liver function blood test panel (HCPCS:80076)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Hemoglobin analysis and measurement, electrophoresis (HCPCS:83020)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous (HCPCS:G0328)

The enumeration date for this NPI number is 10/28/2006 and was last updated on 8/15/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.